Related Experiment Video
Updated: Jul 16, 2026

09:19
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
Improving shared decision-making in advanced Parkinson's disease: protocol of a mixed methods feasibility study
Frouke A P Nijhuis1,2, Glyn Elwyn3, Bastiaan R Bloem4
11Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.
Pilot and Feasibility Studies
|July 13, 2018
Summary
This study tested a shared decision-making (SDM) intervention for advanced Parkinson's disease (PD). The feasibility of this approach, involving patient decision aids and professional training, was evaluated.
Area of Science:
- Neurology
- Health Services Research
- Decision Science
Background:
- Advanced Parkinson's disease (PD) presents complex treatment choices for patients and neurologists.
- Shared decision-making (SDM) integrates evidence, clinical expertise, and patient preferences for optimal treatment selection.
Purpose of the Study:
- To assess the feasibility of an SDM intervention for advanced PD.
- Objectives include analyzing user acceptability, implementation levels, small-scale efficacy, and study procedure evaluation.
Main Methods:
- An uncontrolled before-after mixed methods design was employed.
- The intervention included an Option Grid™ decision aid, supplementary website, and value clarification tool.
- Professionals received SDM training; data collected via questionnaires, interviews, and observations.
Main Results:
- Feasibility was assessed through user acceptability, implementation, and preliminary efficacy.
- Mixed methods analysis provided insights into SDM intervention impact on professional-patient interactions.
Conclusions:
- The SDM intervention's feasibility and impact on decision-making interactions were evaluated.
- Findings will inform the design of a future randomized controlled trial (RCT) to test SDM effectiveness in advanced PD.
Related Concept Videos
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...

